Related Experiment Video
Updated: Aug 23, 2025
07:07
Synthetic Methodology for Asymmetric Ferrocene Derived Bio-conjugate Systems via Solid Phase Resin-based Methodology
Published on: March 12, 2015
9.8K
A Ru(II)-arene-ferrocene complex with promising antibacterial activity
Stephen Mensah1, Joseph D Rosenthal1, Mamta Dagar2
1Department of Chemistry, Illinois State University, Normal, IL, 61790, USA. mwebb@geneseo.edu.
Dalton Transactions (Cambridge, England : 2003)
|November 4, 2022
Summary
Novel ruthenium-based metal complexes with ferrocene show potent antibacterial activity against resistant strains like methicillin-resistant Staphylococcus aureus (MRSA). These metal-based therapeutics offer a promising new direction for developing effective treatments against challenging infections.
Area of Science:
- Medicinal Chemistry
- Inorganic Chemistry
- Microbiology
Background:
- Rising bacterial virulence necessitates novel antimicrobial agents.
- Metal-based therapeutics offer unique mechanisms of action against resistant infections.
- Ferrocene and ruthenium complexes show potential as bioactive compounds.
Purpose of the Study:
- To synthesize and evaluate novel ruthenium(II)-arene complexes with ferrocene-containing Schiff base ligands.
- To investigate the structure-activity relationships of these metal complexes.
- To assess their efficacy against clinically relevant bacterial strains.
Main Methods:
- Synthesis of ruthenium(II)-arene complexes incorporating ferrocene-appended Schiff base ligands.
- Evaluation of antibacterial activity using minimum inhibitory concentration (MIC) assays.
- Structure-activity relationship analysis to identify key structural features.
Main Results:
- A specific complex, C2, demonstrated significant antibacterial activity.
- The presence of a phenyl group between the Schiff base imine and ferrocene was crucial for activity.
- Complex C2 exhibited a minimum inhibitory concentration of 16 μg mL⁻¹ against methicillin-resistant Staphylococcus aureus (MRSA).
Conclusions:
- The synthesized ruthenium-ferrocene complexes represent a promising class of novel antibacterial agents.
- Complex C2 is a potent lead compound for further development against resistant bacterial infections.
- This study highlights the potential of metal-based compounds in combating antimicrobial resistance.
